High levels of VEGFR 2 expression may contribute to a change in TSP-1 initiated CD36 signaling in different types of cancer including breast, brain, colon, lung, and skin cancer [15, 30, 31, 44, 52–57]. This evidence concerns the gene THBS1 and cancer.